$FULC

$3.64 -$0.04 (1.09%) Close

$FULC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 76.3M shares outstanding

Who owns FULC?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 57.4%

BlackRock, Inc. 11.6% · Montanova Capital, LLC 4.8%

Institutional ownership

100.0%

+6.0 pts vs last qtr

Institutional holders

152

-17 vs last qtr

Net shares bought

+6.5M

by institutions in Q2 2026

New / sold out

28 / 45

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

EcoR1 Capital, LLC NEW +6.5M
Tang Capital Management LLC NEW +6.5M

Biggest sellers in Q2 2026

Ra Capital Management, L.P. SOLD OUT −6.1M
TCG Crossover Management, LLC SOLD OUT −5.3M

Who is planning to sell?

Notices of proposed sale, last 12 months

$54.8M

5 notices from 5 people

Shares covered

4.3M

5.58% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

RA Capital Healthcare Fund LP 10% stockholder $54.2M
Robert J Gould Director 10b5-1 $438K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+149.9%

+20.10% a year

Each share's claim on the business

−60.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $73.6M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years35% 3–5 years13% 1–3 years18% Under 1 year33%

Quarterly turnover

51.6%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting FULC on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	8.8M	11.57%	+3.4M (+63.7%)	≤2021	0.0%
Shares held by quarter Peak holding8.8M (Q2'26) Change over 8 quarters+3.1M Share of the company11.570% BlackRock, Inc.'s full portfolio →
MC Montanova Capital, LLC	3.7M	4.82%	−2.9M (−43.9%)	≤2021	0.3%
Shares held by quarter Peak holding6.6M (Q4'25) Change over 8 quarters+2.5M Share of the company4.820% Montanova Capital, LLC's full portfolio →

BlackRock, Inc.

8.8M

% of company

11.57%

Change vs last qtr

+3.4M (+63.7%)

Held since

≤2021

Montanova Capital, LLC

3.7M

% of company

4.82%

Change vs last qtr

−2.9M (−43.9%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Fulcrum Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting FULC on Form N-PORT; together they hold 20.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AL abrdn Life Sciences Investors abrdn Life Sciences Investors	$11.6M	1.5M	1.99%	2.08%	March 31, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$7.59M	2.1M	2.72%	0.00%	June 30, 2026

abrdn Life Sciences Investors

Position value

$11.6M

% of company

1.99%

% of the fund

2.08%

As of

March 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$7.59M

% of company

2.72%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Fulcrum Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GR Gould Robert J Insider	454.9K	0.60%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.600% Gould Robert J's insider activity →
TG Tourangeau Greg Insider	14.1K	0.02%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.020% Tourangeau Greg's insider activity →

Gould Robert J

Insider

454.9K

% of company

0.60%

Change vs last qtr

—

Held since

—

Tourangeau Greg

Insider

14.1K

% of company

0.02%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Fulcrum Therapeutics, Inc..

Comments